The stroke and a new diagnostic method by Valle Lozano, Kevin & Universitat Autònoma de Barcelona. Facultat de Biociències
Stroke 
Ischemic 
Stroke 
Focal 
AIT 
Cerebral 
Infarct 
Atherothrombotic 
Cardioembolic 
Lacunar 
Unusual cause 
Undetermined cause 
Carotid (TACI, PACI) 
Vertetrobasilar (POCI) 
Lacunar (LACI) 
Global 
Hemorrhagic 
Stroke 
Intracerebral 
Parenchymal 
Lobar 
Deep 
Hemorrhage 
Brainstem 
Cerebellar 
Ventricular 
Subarachnoid 
hemorrhage 
The Stroke and a New Diagnostic Method 
 
The main aim of this project consists on making a comprehensive bibliographic research of the information related with stroke, with the purpose of understanding this disease. The 
information will allow an introduction of cerebrovascular injury, of its symptoms in patients and of its incidence in society. 
More specifically, the treatment methods used today will be sought, and an analysis of the bottlenecks or weak points of these treatments will be made, proposing improvements. 
In addition, taking into account the molecular mechanisms involved in the disease, a bibliographic research of articles, journals and patents will be made, in order to propose or 
develop a faster and safer new methodology than current methods in the diagnosis and treatment of stroke. 
Figure 2A: Geographic distribution 
of mortality from stroke . 
Figure 2B: Geographic distribution 
of disease burden from stroke . 
 
(World Health Organization Global 
Burden of Disease Program, 2004) 
Figure 1: Stroke classification according to its nature. AIT: refers to a transient 
ischemic attack. TACI: total anterior circulation infarct. PACI: partial anterior 
circulation infarct. POCI: infarction of the posterior circulation. LACI: lacunar infarct.  
There are also conditions which mimic stroke, called “stroke 
mimicking conditions”, which are not true stroke and must be 
properly diagnosed in order to administer a therapy 
compatible with the diagnosis to the patient.  
Mimicking Conditions 
1. Onset of symptoms 
• Loss of strength in the face, arm or 
leg, along with tingling sensation. 
• Total or partial vision in one or both 
eyes can be lost. 
• Sudden alteration of speech. 
• Headache with sudden onset. 
• Intense feeling of vertigo, 
instability, imbalance or sudden 
drops. 
2. General evaluation by extra-hospitalary services 
1. A professional will place the patient at 30ºC. 
2. Airway ventilation will be checked. It is necessary to 
ensure the permeability of the airway and ensure 
proper ventilation. 
3. Blood circulation will be checked, evaluating and 
ensuring a good peripheral perfusion. 
4. Neurological assessment will be made, emphasizing 
on the evolution time of symptoms. 
The patient is 
suffering a stroke 
The patient is suffering 
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Priority 1 
Patient within 4 hours of 
symptom development. 
Patients in coma with the 
suspect of a vascular 
cerebral origin. 
Priority 2 
Patients with an evolution 
time of symptoms over 4 
hours and below 12 hours. 
Non priority 
The rest of patients are not 
prioritized. they are moved 
to the emergency service 
without the activation of 
stroke code. 
Stroke Code Activation 
Exclusion criteria of Stroke 
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Diagnosis Stroke classification according its nature 
Stroke Worldwide 
In Catalonia, there are approximately 15,000 cases of stroke each 
year, according to the Grup d’Estudi de Malalties Cerebrovasculars 
(GEECV) from the Spanish Society of Neurology. Its prevalence, 
according to the Health Survey of Catalonia in 2002, is 1.8% in men 
and 1.4% in women, of all ages, but mostly older. More than 60% 
of people affected by stroke die or suffer a disability. 
According to the record of hospital discharge data from the 
Catalan Health Service, from 65 general hospitals (91% of the 
total) 12,335 cases defined as acute cerebrovascular disease were 
reported in 2002. 
Cerebrovascular disease brings 9.2% of global mortality in 
Catalonia; 7.5% in men and 11.1% in women. 
3. Hospital management 
Immediate diagnosis should 
include a clinical and topographic 
vascular diagnosis, location and 
extent of affected brain tissue and 
neurological assessment degree by 
scales, like the NIHSS scale. 
• A clinical assessment with neurological exploration 
will be done according to scales. 
• Extract blood for analysis (CBC, coagulation studies…) 
• A TAC or MRI have to be done. 
• Constants and neurological state have to be 
monitored. 
• Airway permeability have to be ensured. 
• Cardiac function have to be controlled. 
• Control of glycemia and blood pressure. 
 
The impact on Catalonia  
The geographic distribution 
of disease mortality (Figure 
2A) appeared similar to the 
patterns seen for burden 
(Figure 2B). 
New diagnostic method 
A 
B 
It is clear that the time for action in this disease is very short, and lots of tests (including TC or MRI) have to 
be done to determine it is an ischemic stroke, hemorrhagic stroke or mimicking conditions, tests which 
require plenty of time. If thrombolytic treatment, like rtPA, is not given within first 6 hours from the onset 
of symptoms, the patient is unlikely to recover from stroke. 
Advantages 
1. Replacement of current methods. 
2. Improvement of diagnosis. 
3. Mortality reduction of stroke patients. 
4. Death and disability states of patients who could 
not receive a treatment because of slowness of 
diagnosis would be avoided. 
5. Health expenditure reduction. 
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There are some open research lines in order to study the molecules 
involved in cerebrovascular injury. If it could be established whether these 
molecules increase or decrease its concentration during stroke, a tool that 
provides rapid and effective diagnosis could be designed. 
